Coiro V, Volpi R, Capretti L, Speroni G, Marchesi C, Vescovi P P, Caffarri G, Colla R, Rossi G, Davoli C
University Clinics of Internal Medicine, Endocrinology, and Psychiatry, School of Medicine, University of Parma, Italy.
Metabolism. 1994 Apr;43(4):514-7. doi: 10.1016/0026-0495(94)90086-8.
Thyrotropin-releasing hormone (TRH) tests were performed in 38 age- and weight-matched obese but otherwise healthy men. In all subjects, total thyroxine (T4) and triiodothyronine (T3) concentrations were in the normal range. According to basal and TRH-stimulated serum thyrotropin (TSH) levels, subjects were divided into the following three groups: group I (n = 14), euthyroid subjects; group II (n = 11), euthyroid subjects with normal basal but abnormally elevated TSH responses to TRH; group III (n = 13), subjects with elevated basal and TRH-induced TSH levels (subclinical hypothyroidism). Basal TSH levels were 1.8 +/- 0.4 mU/L in group I, 1.7 +/- 0.3 in group II, and 6.0 +/- 0.7 in group III. In both groups II and III, TRH-induced TSH increments were above the normal range (maximal increment > 14 mU/L) and were significantly higher than in group I. The definition of euthyroidism for groups I and II and of subclinical hypothyroidism for group III according to the basal levels of TSH was confirmed by clinical (Billewicz index), hormonal (serum free-T4 levels), and metabolic (serum apoprotein [apo] AI levels) parameters. Basal concentrations of growth hormone (GH) were similar in all groups. When GH levels after TRH stimulation were measured, significant increments (peak minus baseline > 5 micrograms/L) were observed in nine of 13 hypothyroid obese men. The overall mean peak GH increase in group III was 4.5 times higher than baseline and was observed at 45 minutes. None of the euthyroid obese subjects of groups I and II showed any significant change in GH levels in response to TRH.(ABSTRACT TRUNCATED AT 250 WORDS)
对38名年龄和体重匹配、肥胖但其他方面健康的男性进行了促甲状腺激素释放激素(TRH)测试。所有受试者的总甲状腺素(T4)和三碘甲状腺原氨酸(T3)浓度均在正常范围内。根据基础和TRH刺激后的血清促甲状腺激素(TSH)水平,受试者被分为以下三组:第一组(n = 14),甲状腺功能正常的受试者;第二组(n = 11),基础TSH正常但对TRH反应异常升高的甲状腺功能正常的受试者;第三组(n = 13),基础和TRH诱导的TSH水平升高的受试者(亚临床甲状腺功能减退)。第一组的基础TSH水平为1.8±0.4 mU/L,第二组为1.7±0.3 mU/L,第三组为6.0±0.7 mU/L。在第二组和第三组中,TRH诱导的TSH增量均高于正常范围(最大增量>14 mU/L),且显著高于第一组。根据TSH基础水平对第一组和第二组甲状腺功能正常以及第三组亚临床甲状腺功能减退的定义,通过临床(比勒维茨指数)、激素(血清游离T4水平)和代谢(血清载脂蛋白[apo]AI水平)参数得到了证实。所有组的基础生长激素(GH)浓度相似。当测量TRH刺激后的GH水平时,13名甲状腺功能减退的肥胖男性中有9名出现了显著增量(峰值减去基线>5微克/升)。第三组的总体平均GH峰值增加比基线高4.5倍,且在45分钟时出现。第一组和第二组甲状腺功能正常的肥胖受试者在TRH刺激后GH水平均未显示出任何显著变化。(摘要截取自250字)